# OnCo record da-trial-trontier (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/da-trial-trontier/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "da-trial-trontier", "NCT07170150" ;
  schema:name "TRONTIER 2 (trontinemab Phase 3)"@en ;
  schema:description "TRONTIER 2 is a Phase 3 study of trontinemab in early symptomatic Alzheimer’s disease. Confirm eligibility only via ClinicalTrials.gov and a clinician."@en ;
  schema:url <https://onco.cc/trials/da-trial-trontier/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07170150> ;
  onco:status "recruiting" ;
  onco:tag "dementia-atlas" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/diagnoses/alzheimers-disease/>, <https://onco.cc/diagnoses/mild-cognitive-impairment/> ;
  onco:drugs <https://onco.cc/drugs/da-trontinemab/> ;
  onco:companies <https://onco.cc/companies/da-roche/> .